Serum Institute seeks EUA for its Covovax vaccine for 12-17 yrs age group

UPSC Practice recommends Serum Institute seeks EUA for its Covovax vaccine for 12-17 yrs age group.

Serum Institute of India has sought emergency use authorisation from India’s drug regulator for its Covid-19 vaccine Covovax for the 12 to 17 year age group Read more

Courtesy: Current Affairs

Learn more